Definition: *Mycoplasma genitalium* (MG) is a common, often asymptomatic, sexually transmitted bacterium.
Transmission: Primarily spread through unprotected vaginal, anal, or oral sexual contact.
Prevalence: Increasingly recognized as a significant cause of urethritis in men and cervicitis, pelvic inflammatory disease (PID), and other reproductive tract infections in women.
Diagnostic Challenge: Difficult to culture, requiring specific Nucleic Acid Amplification Tests (NAATs) for accurate diagnosis, as it's not detected by routine STI panels.
🤒 Associated Symptoms
In Men: Urethritis symptoms such as dysuria (painful urination), penile discharge, and sometimes proctitis (rectal inflammation) in cases of anal sex.
In Women: Cervicitis symptoms including vaginal discharge, intermenstrual bleeding, post-coital bleeding, and lower abdominal pain. Urethritis with dysuria may also occur.
Pelvic Inflammatory Disease (PID): Can manifest with lower abdominal pain, fever, dyspareunia (painful intercourse), and irregular bleeding.
Asymptomatic Infection: A significant proportion of infected individuals, particularly women, may experience no symptoms, leading to delayed diagnosis and potential transmission.
Complications: Untreated MG can lead to chronic urethritis, epididymitis in men, and PID, infertility, ectopic pregnancy, and chronic pelvic pain in women.
🛡 Crucial Precautions
Consistent Condom Use: Utilize condoms correctly and consistently during all sexual activity to reduce the risk of transmission.
Regular STI Screening: Individuals with new or multiple sexual partners, or those experiencing symptoms, should undergo regular screening, specifically requesting MG testing if indicated.
Partner Notification and Treatment: All current and recent sexual partners must be informed, tested, and treated simultaneously to prevent reinfection and further spread.
Treatment Adherence: Complete the entire course of prescribed antibiotics, even if symptoms improve, to ensure eradication of the infection and prevent resistance.
Abstinence During Treatment: Avoid all sexual contact until treatment is completed and a test of cure (if recommended) confirms the infection has cleared.
🍽 Dietary Directions & Restrictions
Hydration: Maintain adequate fluid intake, especially during antibiotic treatment, to support kidney function and overall well-being.
Probiotic Support: Consider incorporating probiotic-rich foods or supplements to help maintain a healthy gut microbiome, which can be disrupted by antibiotics.
Alcohol Restriction: Avoid alcohol consumption during antibiotic therapy, as it can interfere with medication efficacy, increase side effects, and potentially prolong recovery.
Avoid Irritants: Limit intake of highly acidic, spicy, or caffeinated foods and beverages if experiencing urinary symptoms, as they may exacerbate discomfort.
⚠️ Attendant Guidelines
Antibiotic Resistance: MG has a high propensity for developing antibiotic resistance, particularly to macrolides (e.g., azithromycin), necessitating careful selection of treatment regimens.
Test of Cure (TOC): A TOC using NAAT is strongly recommended 3-4 weeks post-treatment, especially for persistent symptoms or high-risk cases, due to high rates of treatment failure.
Co-infection Screening: Always screen for other common sexually transmitted infections (e.g., Chlamydia, Gonorrhea, HIV, Syphilis) as co-infections are frequent.
Pregnancy Considerations: MG infection during pregnancy can be associated with adverse outcomes; treatment decisions require careful clinical judgment.
🩺 Physician's Perspective
Accurate Diagnosis is Key: Emphasize the importance of specific NAAT testing for MG, as it is often overlooked by standard STI panels, leading to persistent symptoms and complications.
Evolving Treatment Protocols: Due to increasing antibiotic resistance, treatment guidelines are dynamic. Sequential therapy (e.g., doxycycline followed by moxifloxacin) is often the preferred approach.
Comprehensive Patient Education: Crucial for ensuring treatment adherence, facilitating partner notification, and understanding the necessity of a test of cure to prevent recurrence and resistance.
Long-term Reproductive Health: Untreated MG can have significant long-term consequences on reproductive health, underscoring the importance of timely and effective management.
🎓 Academic & Nursing Corner
Patient Counseling: Nurses play a vital role in educating patients about safe sexual practices, the importance of completing antibiotic courses, and partner management strategies.
Sample Collection: Proper technique for collecting urethral, cervical, or rectal swabs for NAAT testing is essential for diagnostic accuracy.
Medication Management: Understanding the specific antibiotic regimens for MG, potential side effects, and drug interactions to provide comprehensive patient guidance.
Follow-up Care: Facilitating scheduling for test of cure appointments and monitoring for resolution of symptoms or potential treatment failures.
🔬 Clinical Reference Index
Etiology: *Mycoplasma genitalium*, a small, wall-less bacterium belonging to the class Mollicutes.
Diagnosis: Primarily by Nucleic Acid Amplification Tests (NAATs) from urine, urethral, cervical, or rectal swabs.
Treatment: Often involves a two-stage regimen, such as doxycycline followed by moxifloxacin, guided by local resistance patterns. Azithromycin may be used if susceptibility is confirmed.
Complications: Non-gonococcal urethritis, cervicitis, pelvic inflammatory disease (PID), epididymitis, proctitis, and potential links to infertility and adverse pregnancy outcomes.
ICD-10 Codes: B96.89 Other specified bacterial agents as the cause of diseases classified elsewhere (for the organism itself); N34.1 Non-gonococcal urethritis; N72 Inflammatory disease of cervix uteri; N73.9 Female pelvic inflammatory disease, unspecified.